+86-27-65522453 sales@sun-shinechem.com


Catalog No.: 1710121
Cas No.: 1632006-28-0
Purity : >98%
1710121 - Esaxerenone | CAS 1632006-28-0

Catalog number : 1710121

CAS number : 1632006-28-0

Molecular Formula : C22H21F3N2O4S

Molecular Weight : 466.4752

Iupac Chemical Name : 1-(2-hydroxyethyl)-4-methyl-N-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide

Smile : CS(C1=CC=C(NC(C2=CN(CCO)C(C3=CC=CC=C3C(F)(F)F)=C2C)=O)C=C1)(=O)=O


PackagingPriceAvailabilityPurityEstimated Shipping Time
Request Bulk Quote Download MSDSTel:+86-27-65522453 | Email:sales@sun-shinechem.com
SynonymsEsaxerenone; CS-3150; CS 3150; CS3150.
Molecular FormulaC22H21F3N2O4S
Molecular Weight466.4752
Appearanceoff-white solid
SolubilitySoluble in DMSO
Storage3 years -20ºCpowder
Shipping ConditionShipped under ambient temperature as non-hazardous chemical.
Coming soon.

Esaxerenone (INN) (developmental code names CS-3150, XL-550) is a nonsteroidal antimineralocorticoid which was discovered by Exelixis and is now under development by Daiichi Sankyo Company for the treatment of hypertension, essential hypertension, hyperaldosteronism, and diabetic nephropathies. It acts as a highly selective silent antagonist of the mineralocorticoid receptor (MR), the receptor for aldosterone, with greater than 1,000-fold selectivity for this receptor over other steroid hormone receptors, and 4-fold and 76-fold higher affinity for the MR relative to the existing antimineralocorticoids spironolactone and eplerenone. As of 2017, esaxerenone is in phase III clinical trials for hypertension, essential hypertension, and hyperaldosteronism and is in phase II clinical trials for diabetic nephropathies.

1632006-28-0 - Request Bulk Quote

1632006-28-0 - Request Bulk Quote